Rb. Veenhuizen et al., FOSCAN-MEDIATED PHOTODYNAMIC THERAPY FOR A PERITONEAL-CANCER MODEL - DRUG DISTRIBUTION AND EFFICACY STUDIES, International journal of cancer, 73(2), 1997, pp. 230-235
Distribution of the photosensitizer Foscan(R) (meta-tetrahydroxyphenyl
chlorin, mTHFC), after i.v. or i.p. injection, was investigated in Wag
/Rij rats bearing i.p. tumours. These results were com pared with the
efficacy of mTHPC-mediated photodynamic therapy for illumination inter
vals of 4 hr to 3 days, For the distribution experiments a single tumo
ur (CC531 colon carcinoma) was implanted intra-abdominally in a fat pa
d, or a cell suspension (1 x 10(6) CC531 cells) was injected into the
peritoneal cavity, which results in a dissemination of tumour nodules
on the peritoneum. C-14-mTHPC was not selectively taken up in the sing
le-tumour model after i.v. or i.p. injection, but higher concentration
s were achieved for i.p. administration, For this tumour model the con
centration ratios between tumour and normal tissue never exceeded a va
lue of 3, In the disseminated-tumour model, an uptake of up to 40% of
the injected dose was found per gram tumour at 4 hr after an i.p. inje
ction and this resulted in very high (> 14) concentration ratios of tu
mour to normal tissues. Low uptake was found after the i.v. injection
route (1% of the injected dose per gram tumour) with lower tumour/norm
al tissue ratios (< 8). The efficacy of i.p. photodynamic therapy (IP-
PDT) was evaluated using the single-tumour model only. The lower abdom
en was illuminated at 4 hr to 3 days after mTHPC, and tumour size was
repeatedly measured via a small laparoscopy, Significant delay in tumo
ur regrowth was achieved for 6 J.cm(-2) at 1 day after i.v., or at 4 h
r after i.p. mTHPC (p values 0.019 and 0.045 respectively), Response t
o PDT, of tumours implanted in the fat pad, was not greater for i.p. a
dministration of the photosensitizer and there was a poor correlation
between times of maximum drug uptake in tumours and optimal illuminati
on times for PDT efficacy. (C) 1997 Wiley-Liss, Inc.